Literature DB >> 10980138

Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment.

M S Seo1, N Okamoto, M A Vinores, S A Vinores, S F Hackett, H Yamada, E Yamada, N L Derevjanik, W LaRochelle, D J Zack, P A Campochiaro.   

Abstract

Expression of platelet-derived growth factor (PDGF)-A and PDGF-B is increased in patients with proliferative retinopathies in which traction retinal detachments occur. Previous studies have demonstrated that increased expression of PDGF-A in the retina of transgenic mice results in retinal gliosis due to proliferation of astrocytes with different retinal phenotypes based on the time of onset and location of the PDGF-A production. In this study, we investigated the effects of PDGF-B in the retina using gain-of-function transgenic mice that express PDGF-B in photoreceptors. These mice show proliferation of astrocytes, pericytes, and, to a lesser extent, endothelial cells, resulting in ectopic cells on the surface and extending into the retina. The sheets of cells exert traction on the retina resulting in traction retinal detachments similar to those seen in humans with proliferative retinopathies. These studies suggest that PDGF-B has more dramatic effects in the retina than PDGF-A, because it acts on additional cell types, in particular on pericytes, which have a highly developed contractile apparatus. These studies in the retina suggest a means that could be used in other tissues throughout the body to achieve graded PDGF effects. They also provide a new model of traction retinal detachment that can be used to investigate new treatments for patients with proliferative retinopathies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980138      PMCID: PMC1885694          DOI: 10.1016/S0002-9440(10)64612-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Method of production and natural history of experimental posterior penetrating eye injury in the rhesus monkey.

Authors:  P E Cleary; S J Ryan
Journal:  Am J Ophthalmol       Date:  1979-08       Impact factor: 5.258

2.  Retinal cryopexy stimulates traction retinal detachment formation in the presence of an ocular wound.

Authors:  P A Campochiaro; H C Gaskin; S A Vinores
Journal:  Arch Ophthalmol       Date:  1987-11

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.

Authors:  D B Chandler; G Rozakis; E de Juan; R Machemer
Journal:  Am J Ophthalmol       Date:  1985-06-15       Impact factor: 5.258

5.  A comparison of different cellular inocula in an experimental model of massive periretinal proliferation.

Authors:  D M Fastenberg; K R Diddie; N Sorgente; S J Ryan
Journal:  Am J Ophthalmol       Date:  1982-05       Impact factor: 5.258

6.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  Experimental Fibroplasia in the rabbit vitreous. Retinal detachment induced by autologous fibroblasts.

Authors:  P Algvere; E Kock
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-05-26

8.  Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy.

Authors:  H Yamada; E Yamada; A Ando; M S Seo; N Esumi; N Okamoto; M Vinores; W LaRochelle; D J Zack; P A Campochiaro
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

9.  Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact.

Authors:  K K Hirschi; S A Rohovsky; L H Beck; S R Smith; P A D'Amore
Journal:  Circ Res       Date:  1999-02-19       Impact factor: 17.367

10.  Histochemical evaluation of mouse and rat kidneys with lectin-horseradish peroxidase conjugates.

Authors:  B A Schulte; S S Spicer
Journal:  Am J Anat       Date:  1983-11
View more
  30 in total

1.  Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.

Authors:  John Doukas; Sankaranarayana Mahesh; Naoyasu Umeda; Shu Kachi; Hideo Akiyama; Katsutoshi Yokoi; Jon Cao; Zoe Chen; Luis Dellamary; Betty Tam; Adrienne Racanelli-Layton; John Hood; Michael Martin; Glenn Noronha; Richard Soll; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2008-07       Impact factor: 6.384

Review 2.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

3.  Sustained delivery of a HIF-1 antagonist for ocular neovascularization.

Authors:  Takeshi Iwase; Jie Fu; Tsunehiko Yoshida; Daisuke Muramatsu; Akiko Miki; Noriyasu Hashida; Lili Lu; Brian Oveson; Raquel Lima e Silva; Christopher Seidel; Ming Yang; Sheila Connelly; Jikui Shen; Bing Han; Mingsheng Wu; Gregg L Semenza; Justin Hanes; Peter A Campochiaro
Journal:  J Control Release       Date:  2013-10-12       Impact factor: 9.776

4.  Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration.

Authors:  Kun Ding; Lucia Eaton; Diana Bowley; Matthew Rieser; Qing Chang; Maria C Harris; Anca Clabbers; Feng Dong; Jikui Shen; Sean F Hackett; Debra S Touw; Jacqueline Bixby; Suju Zhong; Lorenzo Benatuil; Sahana Bose; Christine Grinnell; Gregory M Preston; Ramesh Iyer; Ramkrishna Sadhukhan; Susan Marchie; Gary Overmeyer; Tariq Ghayur; Deborah A van Riet; Shibo Tang; Peter A Campochario; Jijie Gu
Journal:  MAbs       Date:  2017 Feb/Mar       Impact factor: 5.857

Review 5.  Glycobiology of ocular angiogenesis.

Authors:  Anna I Markowska; Zhiyi Cao; Noorjahan Panjwani
Journal:  Glycobiology       Date:  2014-08-08       Impact factor: 4.313

Review 6.  Microvascular modifications in diabetic retinopathy.

Authors:  Jennifer T Durham; Ira M Herman
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

7.  Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A.

Authors:  Aling Dong; Christopher Seidel; Daniel Snell; Savira Ekawardhani; Julia K J Ahlskog; Michael Baumann; Jikui Shen; Takeshi Iwase; Jing Tian; Rebecca Stevens; Sean F Hackett; Michael T Stumpp; Peter A Campochiaro
Journal:  Angiogenesis       Date:  2013-10-24       Impact factor: 9.596

Review 8.  Ocular neovascularization.

Authors:  Peter A Campochiaro
Journal:  J Mol Med (Berl)       Date:  2013-01-18       Impact factor: 4.599

Review 9.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

10.  Repression of retinal microvascular endothelial cells by transthyretin under simulated diabetic retinopathy conditions.

Authors:  Jun Shao; Yong Yao
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.